Clinical Roundup Individuals with inflammatory breast cancer at higher risk of cancer spread to the brain October 14, 2022Vol.48 No.37
Clinical Roundup Allogene initiates first allogeneic CAR T phase II trial October 14, 2022Vol.48 No.37
Clinical Roundup Female cancer patients report less satisfaction, more challenges with cancer care October 14, 2022Vol.48 No.37
Clinical Roundup Wistar scientists identify link between mitochondria and pancreatic cancer risk October 14, 2022Vol.48 No.37
Drugs & Targets Health Canada approves Merck’s Keytruda as post-surgery monotherapy in kidney cancer patients October 14, 2022Vol.48 No.37
Drugs & Targets Eclipse and Mayo create Nucleus RadioPharma to improve radiopharmaceutical manufacturing October 14, 2022Vol.48 No.37
NCI Thrice Acting Director Lowy lays out vision of NCI future as Bertagnolli steps in October 07, 2022Vol.48 No.36By Matthew Bin Han Ong
Conversation with The Cancer Letter Thyme Care founders talk about the business of patient navigation October 07, 2022Vol.48 No.36By Paul Goldberg
In Brief Elizabeth Jaffee, Electra Paskett, Pelotonia win 2022 AACI Awards October 07, 2022Vol.48 No.36
In Brief William Calo named co-leader of Cancer Control Program at Penn State Cancer Institute October 07, 2022Vol.48 No.36
